dexfenfluramine has been researched along with Heart Valve Diseases in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (39.53) | 18.2507 |
2000's | 22 (51.16) | 29.6817 |
2010's | 2 (4.65) | 24.3611 |
2020's | 2 (4.65) | 2.80 |
Authors | Studies |
---|---|
Donis, N; Dulgheru, R; Fillet, M; Hego, A; Hulin, A; Lancellotti, P; Maréchal, P; Nchimi, A; Nguyen, ML; Oury, C; Tridetti, J | 1 |
Ceulemans, B; Gammaitoni, A; Keane, MG; Lagae, L; Marchau, F; Paelinck, BP; Pringsheim, M; Schoonjans, AS | 1 |
Bruneval, P; Ennezat, PV; Malergue, MC; Ohanessian, A; Zannis, K | 1 |
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH | 1 |
Golbraikh, A; Grulke, CM; Hajjo, R; Huang, XP; Roth, BL; Setola, V; Tropsha, A | 1 |
Derry, S; Loke, YK; Pritchard-Copley, A | 1 |
Rigolin, VH; Seghatol, FF | 1 |
Decker, P; Gelgand, EA; Prasad, A; Roldan, CA; Shively, BK | 1 |
Gross, SB; Lepor, NE | 1 |
Jollis, JG; Miller, WC; Ryan, T; Sachdev, M | 1 |
Gross, SB; Naqvi, TZ | 1 |
Hess, MA | 1 |
Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY | 1 |
Baird, IM | 1 |
Cherin, P; Godeau, P; Tellier, P | 1 |
Aurigemma, G; Douglas, PS; Erban, S; Kriegel, G; Phillips, RS; Riley, M; Wee, CC | 1 |
Parisi, AF | 1 |
Williamson, DF; Yanovski, SZ | 1 |
Annegers, JF; Moyé, LA | 1 |
Myers, MD | 1 |
Shapiro, S | 1 |
Pallasch, TJ | 1 |
Adams, C; Cohen, A | 1 |
Ellis-Pegler, RB; Hay, KD; Lang, SD; Neutze, JM; Swinburn, BA | 1 |
Ewalenko, M; Richard, C; Vandenbossche, JL | 1 |
SoRelle, R | 1 |
Schultz, S | 1 |
Foreyt, JP; Poston, WS | 1 |
Constantine, G; Davis, KD; Gardin, JM; Leung, C; Reid, CL; Schumacher, D | 1 |
Jick, H | 1 |
Gross, SB | 1 |
Alexander, RE | 1 |
Gill, EA; Roldan, CA; Shively, BK | 1 |
Ballmer, PE; Imoberdorf, R | 1 |
Cheng, TO | 1 |
Ryan, DH | 1 |
Weissman, NJ | 1 |
Carpenter, W; Rudin, R | 1 |
Caccitolo, JA; Connolly, HM; Orszulak, TA; Rubenson, DS; Schaff, HV | 1 |
Bergmann, JF | 1 |
13 review(s) available for dexfenfluramine and Heart Valve Diseases
Article | Year |
---|---|
Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.
Topics: Adult; Appetite Depressants; Dexfenfluramine; Epilepsies, Myoclonic; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Incidence; Obesity; Phentermine | 2017 |
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents | 2009 |
Appetite suppressants and valvular heart disease - a systematic review.
Topics: Appetite Depressants; Clinical Trials as Topic; Cohort Studies; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Phentermine | 2002 |
Appetite suppressants and valvular heart disease.
Topics: Appetite Depressants; Carcinoid Heart Disease; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Phentermine; Ultrasonography | 2002 |
Anorexigen-related cardiopulmonary toxicity.
Topics: Aminorex; Appetite Depressants; Dexfenfluramine; Echocardiography; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Phentermine | 2000 |
Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
Topics: Aortic Valve Insufficiency; Appetite Depressants; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Heart Valves; Humans; Mitral Valve Insufficiency; Phentermine; Serotonin Agents | 2002 |
Anorexigen-induced cardiac valvulopathy and female gender.
Topics: Adult; Appetite Depressants; Dexfenfluramine; Echocardiography; Female; Fenfluramine; Heart Valve Diseases; Humans; Middle Aged; Obesity; Phentermine; Serotonin Receptor Agonists | 2003 |
Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.
Topics: Antibiotic Prophylaxis; Appetite Depressants; Dental Care for Chronically Ill; Dexfenfluramine; Drug Combinations; Endocarditis, Bacterial; Female; Fenfluramine; Heart Valve Diseases; Humans; Male; Phentermine; Practice Guidelines as Topic; Prevalence | 1999 |
Scientific and legal issues in fenfluramine/dexfenfluramine litigation.
Topics: Anti-Obesity Agents; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Legislation, Medical; Neurotoxicity Syndromes; Risk Assessment; Science; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Weight Loss | 2000 |
Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
Topics: Appetite Depressants; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Nurse Practitioners; Obesity; Phentermine; Practice Guidelines as Topic; Predictive Value of Tests; Prevalence; Risk Factors; Selective Serotonin Reuptake Inhibitors; United States | 1999 |
[Obesity: principles of drug therapy].
Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Diet, Reducing; Drug and Narcotic Control; Germany; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Lactones; Obesity; Orlistat; Phentermine | 2000 |
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phenylpropanolamine; Serotonin Agents; Weight Loss | 2000 |
Appetite suppressants and valvular heart disease.
Topics: Age Factors; Appetite Depressants; Dexfenfluramine; Drug Therapy, Combination; Fenfluramine; Heart Valve Diseases; Humans; Multicenter Studies as Topic; Obesity; Phentermine; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2001 |
30 other study(ies) available for dexfenfluramine and Heart Valve Diseases
Article | Year |
---|---|
Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling.
Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cluster Analysis; Dexfenfluramine; Enzyme Activation; Extracellular Matrix; Female; Gene Expression Regulation; Heart Valve Diseases; Homeostasis; MicroRNAs; p38 Mitogen-Activated Protein Kinases; Pergolide; Rabbits; Sequence Analysis, RNA; Serotonin; Transcriptome; Transforming Growth Factor beta; Tricuspid Valve | 2020 |
Dexfenfluramin: a forgotten cause of aortic stenosis.
Topics: Aortic Valve Stenosis; Appetite Depressants; Chemically-Induced Disorders; Dexfenfluramine; Echocardiography, Doppler; Endocardium; Exercise Test; Female; Fibrosis; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Middle Aged; Obesity; Tomography, X-Ray Computed | 2020 |
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.
Topics: Algorithms; Binding, Competitive; Databases, Factual; Dexfenfluramine; Drug-Related Side Effects and Adverse Reactions; Fenfluramine; Heart Valve Diseases; Ligands; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists | 2010 |
Morphology of anorexigen-associated valve disease by transthoracic and transesophageal echocardiography.
Topics: Adult; Aortic Valve; Appetite Depressants; Body Mass Index; Dexfenfluramine; Drug Combinations; Echocardiography, Transesophageal; Female; Fenfluramine; Heart Valve Diseases; Humans; Middle Aged; Mitral Valve; Obesity; Phentermine | 2002 |
Taking things to heart.
Topics: Appetite Depressants; Dexfenfluramine; Drug Combinations; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phentermine | 2004 |
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain | 2006 |
Risks of heart-valve abnormalities with appetite suppressants.
Topics: Appetite Depressants; Dexfenfluramine; Female; Fenfluramine; Heart Valve Diseases; Humans; Risk Factors | 1998 |
[Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
Topics: Animals; Aortic Valve Insufficiency; Appetite Depressants; Dexfenfluramine; Female; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Middle Aged; Mitral Valve Insufficiency; Phentermine; Risk Factors | 1998 |
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
Topics: Adult; Appetite Depressants; Cohort Studies; Dexfenfluramine; Disease Progression; Echocardiography; Female; Fenfluramine; Follow-Up Studies; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Single-Blind Method; Statistics, Nonparametric | 1998 |
Diet-drug debacle.
Topics: Appetite Depressants; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; United States; United States Food and Drug Administration | 1998 |
Studies confirm link between fen-phen and heart-valve disease.
Topics: Appetite Depressants; Cyclobutanes; Dexfenfluramine; Drug Combinations; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phentermine | 1998 |
Appetite-suppressant drugs and valvular heart disease.
Topics: Appetite Depressants; Data Interpretation, Statistical; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Prevalence; Risk | 1999 |
Appetite-suppressant drugs and valvular heart disease.
Topics: Appetite Depressants; Confidence Intervals; Dexfenfluramine; Dose-Response Relationship, Drug; Heart Valve Diseases; Humans; Prevalence; Research Design; Risk | 1999 |
Appetite-suppressant drugs and valvular heart disease.
Topics: Appetite Depressants; Dexfenfluramine; Heart Valve Diseases; Humans; Incidence; Obesity; Research Design | 1999 |
Appetite-suppressant drugs and valvular heart disease.
Topics: Appetite Depressants; Bias; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Odds Ratio; Phentermine; Prevalence | 1999 |
[Appetite suppressants and heart valve disorders].
Topics: Adult; Aged; Aortic Valve Insufficiency; Appetite Depressants; Dexfenfluramine; Female; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Middle Aged; Mitral Valve Insufficiency; Phentermine; Pulmonary Valve Insufficiency; Serotonin Agents; Serotonin Receptor Agonists | 1999 |
Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation.
Topics: Adult; Anti-Obesity Agents; Antibiotic Prophylaxis; Aortic Valve Insufficiency; Cefuroxime; Cephalosporins; Child; Child, Preschool; Dental Care; Dexfenfluramine; Drug Prescriptions; Endocarditis, Bacterial; Fenfluramine; Heart Diseases; Heart Valve Diseases; Humans; Mitral Valve Insufficiency; Prodrugs; Risk Factors; Serotonin Receptor Agonists | 1999 |
[Fenfluramines and cardiac valvular lesions].
Topics: Adult; Aged; Dexfenfluramine; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Fenfluramine; Follow-Up Studies; Heart Valve Diseases; Humans; Mass Screening; Middle Aged; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Time Factors | 1999 |
Diet drug maker agrees to $3.75 billion settlement.
Topics: Dexfenfluramine; Drug Industry; Fenfluramine; Heart Valve Diseases; Humans; United States | 1999 |
A big fat settlement. But lawyers for diet-drug users suggest that $3.75 billion is not nearly enough.
Topics: Appetite Depressants; Dexfenfluramine; Drug Industry; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Liability, Legal; Serotonin Receptor Agonists; United States | 1999 |
Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
Topics: Aortic Valve Insufficiency; Appetite Depressants; Body Mass Index; Dexfenfluramine; Echocardiography, Doppler; Female; Fenfluramine; Heart Valve Diseases; Heart Valves; Humans; Logistic Models; Male; Matched-Pair Analysis; Middle Aged; Mitral Valve Insufficiency; Obesity; Phentermine; Prevalence; Risk; Serotonin Agents; Statistics, Nonparametric | 2000 |
Heart valve disorders and appetite-suppressant drugs.
Topics: Appetite Depressants; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Phentermine; Serotonin Agents | 2000 |
More on heart disease and diet pills.
Topics: Appetite Depressants; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Serotonin Agents | 2000 |
Cardiac valvulopathy.
Topics: Antibiotic Prophylaxis; Appetite Depressants; Dental Care; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Phentermine; Practice Guidelines as Topic; Risk Factors | 2000 |
Prevalence and diagnostic value of precordial murmurs for valvular regurgitation in obese patients treated with dexfenfluramine.
Topics: Case-Control Studies; Dexfenfluramine; Echocardiography, Doppler, Color; Female; Heart Auscultation; Heart Murmurs; Heart Valve Diseases; Humans; Male; Middle Aged; Obesity; Prevalence; Serotonin Receptor Agonists | 2000 |
Fen/Phen and valvular heart disease: the final link has now been established.
Topics: Dexfenfluramine; Heart Valve Diseases; Humans; Prognosis; Serotonin Receptor Agonists | 2000 |
Diet drugs and cardiac valvulopathy: a survey of dental patients.
Topics: Adult; Antibiotic Prophylaxis; Appetite Depressants; Dental Care; Dexfenfluramine; Endocarditis, Bacterial; Fenfluramine; Follow-Up Studies; Heart Valve Diseases; Humans; Phentermine; Prevalence; Serotonin Agents; Serotonin Receptor Agonists; Surveys and Questionnaires | 2000 |
Valve disease due to appetite suppressants (cont'd).
Topics: Aortic Valve; Appetite Depressants; Clinical Trials as Topic; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Mitral Valve; Phentermine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Operation for anorexigen-associated valvular heart disease.
Topics: Adult; Appetite Depressants; Dexfenfluramine; Female; Fenfluramine; Heart Valve Diseases; Humans; Middle Aged; Phentermine; Serotonin Agents; Serotonin Receptor Agonists; Ultrasonography | 2001 |
[Facts, fakes and "biblio". Do internists still have something to learn about dexfenfluramine?].
Topics: Dexfenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Obesity; Serotonin Antagonists | 2001 |